• Home
  • Stock
  • Cohance Lifesciences Fundamental Analysis
  • Cohance Lifesciences Fundamental Analysis

Cohance Lifesciences fundamental analysis

COHANCE

HealthcareLarge

560.5

9.30 (-1.63%)
Last updated on 25 Nov, 2025 | 12:59 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Cohance Lifesciences Fundamentals

P/E Ratio

90.86

P/B Ratio

5.95

Div. Yield

0

Sector P/E

37.28

Sector P/B

3.6

Sec. Div. Yield

0.57

  • Cohance Lifesciences Fundamentals is currently trading with a P/E Ratio of 90.86, compared to the sector average of 37.28. Its P/B Ratio stands at 5.95, while the sector’s is 3.6. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.

Cohance Lifesciences Score Card

  • Price

    Attractive

  • Growth

    Moderate

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Cohance Lifesciences reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.